QUIDELORTHO CORP Interest Income (Expense), Nonoperating, Net
QUIDELORTHO CORP (QDEL) reported Interest Income (Expense), Nonoperating, Net of -$54.70 million for the 3-month period ending 2026-06-28, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Other Income
us-gaap:InterestIncomeExpenseNonoperatingNet · last filed 2026-08-07
- QUIDELORTHO CORP interest income (expense), nonoperating, net for the quarter ending 2026-06-28 was -$54.70M.
- QUIDELORTHO CORP interest income (expense), nonoperating, net for the quarter ending 2026-03-29 was -$51.10M.
- QUIDELORTHO CORP interest income (expense), nonoperating, net for the quarter ending 2025-12-28 was -$51.00M.
- QUIDELORTHO CORP interest income (expense), nonoperating, net for the quarter ending 2025-09-28 was -$46.10M.
- QUIDELORTHO CORP interest income (expense), nonoperating, net for fiscal 2025 was -$177.60M.
- QUIDELORTHO CORP interest income (expense), nonoperating, net for fiscal 2024 was -$163.50M.
- QUIDELORTHO CORP interest income (expense), nonoperating, net for fiscal 2023 was -$147.60M.
- QUIDELORTHO CORP interest income (expense), nonoperating, net for fiscal 2023 was -$75.70M.
| Period end | Interest Income (Expense), Nonoperating, Net 3 month | Interest Income (Expense), Nonoperating, Net 6 month | Interest Income (Expense), Nonoperating, Net 9 month | Interest Income (Expense), Nonoperating, Net 12 month |
|---|---|---|---|---|
| 2026-06-28 | -$54.70M 10-Q · filed 2026-08-07 | -$105.80M 10-Q · filed 2026-08-07 | -$156.80M derived: sum of 3 quarters · filed 2026-08-07 | -$202.90M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-29 | -$51.10M 10-Q · filed 2026-05-06 | -$102.10M derived: sum of 2 quarters · filed 2026-05-06 | -$148.20M derived: sum of 3 quarters · filed 2026-05-06 | -$188.70M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-28 | -$51.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | -$97.10M derived: sum of 2 quarters · filed 2026-02-19 | -$137.60M derived: sum of 3 quarters · filed 2026-08-07 | -$177.60M 10-K · filed 2026-02-19 |
| 2025-09-28 | -$46.10M 10-Q · filed 2025-11-06 | -$86.60M derived: sum of 2 quarters · filed 2026-08-07 | -$126.60M 10-Q · filed 2025-11-06 | -$167.20M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-29 | -$40.50M 10-Q · filed 2026-08-07 | -$80.50M 10-Q · filed 2026-08-07 | -$121.10M derived: sum of 3 quarters · filed 2026-08-07 | -$164.00M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-30 | -$40.00M 10-Q · filed 2026-05-06 | -$80.60M derived: sum of 2 quarters · filed 2026-05-06 | -$123.50M derived: sum of 3 quarters · filed 2026-05-06 | -$164.50M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-29 | -$40.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | -$83.50M derived: sum of 2 quarters · filed 2026-02-19 | -$124.50M derived: sum of 3 quarters · filed 2026-02-19 | -$163.50M 10-K · filed 2026-02-19 |
| 2024-09-29 | -$42.90M 10-Q · filed 2025-11-06 | -$83.90M derived: sum of 2 quarters · filed 2025-11-06 | -$122.90M 10-Q · filed 2025-11-06 | |
| 2024-06-30 | -$41.00M 10-Q · filed 2025-08-06 | -$80.00M 10-Q · filed 2025-08-06 | ||
| 2024-03-31 | -$39.00M 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | -$147.60M 10-K · filed 2026-02-19 | |||
| 2023-01-01 | -$75.70M 10-K · filed 2025-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |